Research confirms safety of breastfeeding for breast cancer survivors with BRCA mutations

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer), do not face an increased risk of recurrence or developing new breast cancers.

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic and muscle-invasive urothelial cancer. In this exclusive MedPage Today video,

November 23, 2024

How effective is Plan B for people with higher BMIs?

After former President Donald Trump won a second term in the White House last week, Kelly Cleland had two women in her neighborhood hit her

November 14, 2024

Biogen to acquire Reata Pharmaceuticals in $7 billion deal

Biogen on Friday said it would acquire Reata Pharmaceuticals, the maker of an approved therapy for a rare neurological condition, in a deal worth $7.3

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.